Skip to main content
Premium Trial:

Request an Annual Quote

Sigma Life Sciences Joins EMBL Training Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma Life Science said today that it is working with the European Molecular Biology Laboratory (EMBL) to train researchers in using its tools in certain areas, including zinc finger nuclease and RNAi technology applications.

The Sigma-Aldrich division is working with EMBL's Advanced Training Centre in Heidelberg, Germany to provide joint training courses in key areas that use Sigma Life Sciences' technologies.

The partnership will provide "joint training courses not only to meet the future challenges in modern science, but to facilitate the networking of young and established scientists, enabling the exchange of ideas to shape the future direction of research," explained Helge Bastian, VP of Marketing for Sigma-Aldrich Research Biotech, in a statement.

EMBL is a basic research institute supported with public funding from 20 European member states.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.